Periodic Reporting for period 1 - AIDA (AIDA: Allergy Immunotherapy based on Designed Allergens)

The AIDA project is pioneering a novel mRNA-based allergy immunotherapy using consensus allergens (CAs) to provide broad-spectrum protection against multiple allergens. Unlike conventional allergen immunotherapy (AIT), which targets single allergens and requires years of...